The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI) Predicts Survival and Tolerance of Ibrutinib Therapy in Patients with CLL: A Multicenter Retrospective Cohort Study

被引：0
|
作者：
Gordon, Max J.
Kaempf, Andy
Sitlinger, Andrea
Salous, Tareq
Alqahtani, Hamood
Churnetski, Michael C.
Wisniewski, Paul
Rivera, Xavier Issac
Patel, Krish
Persky, Daniel O.
Cohen, Jonathon B.
Choi, Michael Y.
Hill, Brian T.
Shadman, Mazyar
Stephens, Deborah M.
Brander, Danielle M.
Park, Byung
Danilov, Alexey
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136808
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Investigating the Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL) on Ibrutinib Therapy: Results from a Phase Ib Study
    Rogers, Kerry A.
    Flinn, Ian W.
    Stephens, Deborah M.
    Kipps, Thomas J.
    Larson, Sarah
    McGarry, Carolyn
    Hassounah, Nadia B.
    Gou, Liangke Connie
    Woo, Janghee
    Byrd, John C.
    BLOOD, 2021, 138
  • [32] DECREASED EXPRESSION OF ADHESION MOLECULES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS OF PATIENTS TREATED WITH IBRUTINIB
    Guarini, A.
    De Propris, M. S.
    Milani, M. L.
    Intoppa, S.
    Faraone, S.
    Peragine, N.
    Mariglia, P.
    Puzzolo, M. C.
    Mauro, F. R.
    Del Giudice, I.
    Foa, R.
    HAEMATOLOGICA, 2017, 102 : 406 - 406
  • [33] Chronic lymphocytic Leukemia (CLL) Ibrutinib in the First Line: Standard for High-risk Patients
    Pickl, Susanne
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (1-2) : 76 - 76
  • [34] Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)
    Jain, Nitin
    Keating, Michael J.
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Burger, Jan A.
    Borthakur, Gautam M.
    Takahashi, Koichi
    Estrov, Zeev E.
    Fowler, Nathan H.
    Kadia, Tapan M.
    Konopleva, Marina Y.
    Alvarado, Yesid
    Yilmaz, Musa
    DiNardo, Courtney D.
    Bose, Prithviraj
    Ohanian, Maro
    Pemmaraju, Naveen
    Jabbour, Elias
    Sasaki, Koji
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Garg, Naveen
    Wang, Xuemei
    Sondermann, Katrina
    Cruz, Nichole
    Wei, Chongjuan
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop M.
    Gandhi, Varsha
    Wierda, William G.
    BLOOD, 2019, 134
  • [35] Combined Ibrutinib and Venetoclax in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
    Jain, Nitin
    Keating, Michael J.
    Thompson, Philip A.
    Burger, Jan A.
    Ferrajoli, Alessandra
    Estrov, Zeev E.
    Borthakur, Gautam M.
    Takahashi, Koichi
    Bose, Prithviraj
    Fowler, Nathan H.
    Kadia, Tapan M.
    Daver, Naval G.
    Konopleva, Marina Y.
    Alvarado, Yesid
    Yilmaz, Musa
    DiNardo, Courtney D.
    Ohanian, Maro
    Pemmaraju, Naveen
    Jabbour, Elias
    Sasaki, Koji
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Garg, Naveen
    Wang, Xuemei
    Sondermann, Katrina
    Cruz, Nichole
    Wei, Chongjuan
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop M.
    Gandhi, Varsha
    Wierda, William G.
    BLOOD, 2019, 134
  • [36] Long-term effects of ibrutinib on blood pressure in patients with chronic lymphocytic leukemia (CLL).
    Jones, Jade
    George, Binsah
    Peterson, Christine B.
    Burger, Jan Andreas
    Jain, Nitin
    Wierda, William G.
    Keating, Michael J.
    Durand, Jean-Bernard
    Ferrajoli, Alessandra
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Open label evaluation of ECG in patients with chronic lymphocytic leukemia (CLL) receiving ibrutinib monotherapy
    Loury, David
    Sukbuntherng, Juthamas
    Clow, Fong
    James, Danelle Frances
    Kunkel, Lori A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Jaglowski, Samantha M.
    Jones, Jeffrey A.
    Flynn, Joseph M.
    Andritsos, Leslie A.
    Maddocks, Kami J.
    Woyach, Jennifer A.
    Blum, Kristie A.
    Greyer, Michael R.
    Geyer, Susan Michelle
    Heerema, Nyla A.
    Lozanski, Gerard
    Stefanos, Mona
    Hall, Nathan
    Nagar, Veena
    Munneke, Brian
    West, Jamie-Sue
    Neuenburg, Jutta K.
    James, Danelle F.
    Johnson, Amy J.
    Byrd, John C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S206 - S207
  • [39] CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) IN YOUNGER ADULTS - A RETROSPECTIVE STUDY OF 133 CASES
    DEROSSI, G
    MANDELLI, F
    COVELLI, A
    LUCIANI, M
    MARTELLI, M
    RESEGOTTI, L
    ALBERTI, A
    CAJOZZO, A
    DERIU, L
    DEBIASI, R
    BROCCIA, G
    ABBADESSA, A
    CARONIA, F
    LEONE, P
    HEMATOLOGICAL ONCOLOGY, 1989, 7 (02) : 127 - 137
  • [40] The causes of death and the impact of age on the survival of patients with chronic lymphocytic leukemia (CLL).
    Flynn, JM
    Byrd, JC
    Diehl, LF
    BLOOD, 1999, 94 (10) : 298B - 298B
12345